KIM-1 AKI Progression Biomarker

Use kidney injury molecule-1 (KIM-1) urine concentration to identify proximal tubular injury, predict AKI progression, and differentiate ATN from prerenal AKI.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Use kidney injury molecule-1 (KIM-1) urine concentration to identify proximal tubular injury, predict AKI progression, and differentiate ATN from prerenal AKI

Each component has a specific meaning:

  • Prerenal AKI — The prerenal aki recorded for the scenario being assessed.

Note: Interpret the kim-1 aki biomarker result against the thresholds and context described above.

How to Use

Enter the prerenal AKI for the scenario you are assessing. Use kidney injury molecule-1 (KIM-1) urine concentration to identify proximal tubular injury, predict AKI progression, and differentiate ATN from prerenal AKI. Use the kim-1 aki biomarker result to inform your calculation.

Frequently Asked Questions